Amarin Corp PLC (id:6537 AMRN)
0.525 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 4:44:36 PM)
Exchange closed, opens in 16 hours 45 minutes
About Amarin Corp PLC
Market Capitalization 203.37M
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
| Headquarters (address) |
Iconic Offices, The Greenway Dublin 112-114 Ireland |
| Phone | 353 0 166 99020 |
| Website | https://www.amarincorp.com |
| Employees | 275 |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Ticker | AMRN |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 0.460 - 1.37 |
| Market Capitalization | 203.37M |
| P/E trailing | -3.27 |
| P/E forward | -2.35 |
| Price/Sale | 0.844 |
| Price/Book | 0.383 |
| Beta | 1.93 |
| EPS | -0.100 |
| EPS Ireland (ID:161, base:53) | 2.57 |